Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)

Bioorganic & Medicinal Chemistry
2008.0

Abstract

Novel cholesterol biosynthesis inhibitors, a group of pyridylethanol(phenylethyl)amine derivatives, were synthesized. Sterol profiling assay in the human hepatoma HepG2 cells revealed that compounds target human lanosterol 14alpha-demethylase (CYP51). Structure-activity relationship study of the binding with the overexpressed human CYP51 indicates that the pyridine binds within the heme binding pocket in an analogy with the azoles.

Knowledge Graph

Similar Paper

Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14α-demethylase (CYP51)
Bioorganic & Medicinal Chemistry 2008.0
Selective inhibition of mammalian lanosterol 14.alpha.-demethylase: a possible strategy for cholesterol lowering
Journal of Medicinal Chemistry 1993.0
Inhibition of Human Sterol Δ7-Reductase and Other Postlanosterol Enzymes by LK-980, a Novel Inhibitor of Cholesterol Synthesis
Drug Metabolism and Disposition 2011.0
Synthesis and biological activities of a novel class of azole-containing antifungal agents
Bioorganic & Medicinal Chemistry Letters 1996.0
Stereoselective synthesis of a new class of potent and selective inhibitors of human Δ8,7-sterol isomerase
Bioorganic & Medicinal Chemistry 2013.0
Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of ( E )- N -(2-(1 H -imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides
Bioorganic & Medicinal Chemistry 2017.0
Organocatalytic synthesis and sterol 14α-demethylase binding interactions of enantioriched 3-(1H-1,2,4-triazol-1-yl)butyl benzoates
Bioorganic & Medicinal Chemistry Letters 2009.0
In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51
European Journal of Medicinal Chemistry 2016.0
N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of imidazolylmethylacridones as cytochrome P-450 enzymes inhibitors
MedChemComm 2012.0